Project Grant HT94252410689
Award Date
7/1/24
Completion Date
6/30/26
Dollars Obligated
$159K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
The Trustees of Indiana University will receive $713,250 through a three-year Project Grant award from the Defense Health Agency to support research targeting SOX11-FAK-mediated immune exhaustion in NF1-associated malignant peripheral nerve sheath tumor (MPNST). The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative solutions...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $713,250 over 3 years to the Trustees of Indiana University (doing business as Indiana University) to conduct research targeting the CENPF-CENPE axis for the prevention and treatment of NF1-associated malignant peripheral nerve sheath tumors. The research aims to develop new approaches for addressing this condition, which impacts military service...
The Trustees of Indiana University were awarded a $1.3 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to prevent post-traumatic epilepsy by inhibiting the initiation of innate immune reaction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
The Defense Health Agency awarded Trustees of Indiana University, doing business as Indiana University, a $704,674 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop a preclinical model for gene therapy of Fanconi anemia group C. Through this award with a completion date of September 29, 2026, Indiana University will perform research to investigate medical solutions for battlefield conditions by developing a preclinical model for a...
Trustees of Indiana University was awarded a $724,697 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to optimize muscle function in composite tissue injuries with segmental bone defects. The three-year award beginning May 1, 2023 will support Indiana University's research efforts to investigate medical solutions for battlefield injuries involving both soft tissue damage and bone loss. Through this funding,...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $158,500.00 to support the development of therapeutic strategies for targeting BET proteins and ALK in rare models of embryonal rhabdomyosarcoma with aggressive variants. The award was granted to the Trustees of Indiana University, doing business as Indiana University, and covers the period from September 30, 2024 to September 29, 2026. The funding will...
The Defense Health Agency awarded a $622,008 project grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on November 1, 2024, with a completion date of October 31, 2026, supports research on "The SAGA Complex as an Essential Regulator of Abnormal Transcription Through De Novo DNA Topology Interactions in Multiple Myeloma." This project grant aims to...
The Trustees of Indiana University, doing business as Indiana University Indianapolis (IU Indianapolis), has been awarded a $1,576,423 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This federal grant, awarded on August 1, 2024, will support research to mitigate therapy resistance by combining CDK4/6 and PI3K/mTOR inhibition in pediatric and adolescent/young adult (AYA) osteosarcoma. The research project aims to develop...
The Trustees of Indiana University received a $525,000 Project Grant award from the Department of the Army Medical Command to support research targeting AXL in preclinical models of plexiform neurofibroma and malignant peripheral nerve sheath tumor chemoprevention. The three-year award, issued on July 1, 2021 under the Military Medical Research and Development program, will fund preclinical research investigating medical solutions for the battlefield by transforming health care for service...
This $487,623 federal Project Grant, awarded on September 30, 2023 by the Defense Health Agency (DHA) under the Military Medical Research and Development CFDA program (12.420), supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The award recipient is the Trustees of Indiana University, doing business as Indiana University, a major public research university with extensive expertise in biomedical sciences research. The project aims to advance...